Constellation Brands Inc (STZ)

The run-up in this has already happened, so consider CB. They report next week His own restaurant sells a lot of CB brands, including Modelo beer. CB's sales YOY are stellar. Beer sales are really strong, based on conversations with other restaurants. Pernod Ricard reported that people are drinking more outside the home as economies reopen. True, STZ paid too much for Canopy, but this is already baked into the stock. Legalizing weed is catching on hard in the U.S., so this is a tailwind. STZ is up only 2% for the year, but he feels there's room to run, like Pernod.

Two weeks it delivered a report beat top and bottom lines, and yet the stock dove. Analysts downgraded. Sellers were fools. STZ is the only grower in the packaged goods space. Managers are conservative--STZ would rather spend money growing their product line like a tech stock, but analysts didn't like all this spending of this cash. STZ stock pulled back and is now up $3 before that pullback, recovering faster than he expected. STZ boasts growth opportunities with a 30% increase in capacity. STZ is spending big on their beers, and bars will reopen soon. Modelo beer is doing incredibly well, with demand outstripping supply. They launched Corona Hard Seltzer is another strong seller. Pacifico beer is a hit with growing Gen Z at 30% even during Covid. STZ has a stake in Canopy Growth and cannabis is being legalized in more and more US states. He predicts Canopy to be profitable in 2022, which will benefit STZ. The market underestimates this partnership. The next time this stock dips, pounce on it.

Constellation has the fastest-growing beers on the markets, even though bars are limited or closed during Covid. The consumer sales are larger than bar sales, though. They report Thursday. The spiked seltzer market is doing well. That said, all their accomplishments aren't pushing the stock up much. Re: their investment in Canopy Growth--the whole cannabis biz depend on a clean sweep by the Democrats in November. domination in Canada.

He sort of follows this. Are well-run and have added long-term shareholder value, though they took a big writedown on their Canopy Growth investment. They also carry a lot of debt. Are better investments out there.

Their investment into Canopy Growth will likely result in write downs. They are pretty expensive on the valuations as well -- 19 times EBITDA and 21 times PE. This is a short for them presently.